Chemoinformaics analysis of 1-METHYLQUINAZOLIN-4-ONE
Molecular Weight | 160.176 | nRot | 0 |
Heavy Atom Molecular Weight | 152.112 | nRig | 5 |
Exact Molecular Weight | 160.064 | nRing | 2 |
Solubility: LogS | -3.279 | nHRing | 1 |
Solubility: LogP | 3.885 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 10 |
No. of Oxygen atom | 1 | No. of Arom Bond | 11 |
nHA | 3 | APOL | 23.3663 |
nHD | 0 | BPOL | 11.7437 |
QED | 0.724 |
Synth | 2.776 |
Natural Product Likeliness | 0.759 |
NR-PPAR-gamma | 0.019 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.006 |
HIA | 0.004 |
CACO-2 | -4.553 |
MDCK | 0.0000291 |
BBB | 0.613 |
PPB | 0.977831 |
VDSS | 3.03 |
FU | 0.0383425 |
CYP1A2-inh | 0.827 |
CYP1A2-sub | 0.904 |
CYP2c19-inh | 0.156 |
CYP2c19-sub | 0.783 |
CYP2c9-inh | 0.32 |
CYP2c9-sub | 0.899 |
CYP2d6-inh | 0.026 |
CYP2d6-sub | 0.836 |
CYP3a4-inh | 0.036 |
CYP3a4-sub | 0.147 |
CL | 10.959 |
T12 | 0.647 |
hERG | 0.004 |
Ames | 0.015 |
ROA | 0.106 |
SkinSen | 0.54 |
Carcinogencity | 0.164 |
EI | 0.831 |
Respiratory | 0.23 |
NR-Aromatase | 0.844 |
Antiviral | No |
Prediction | 0.780665 |